ROGERS CORP

Listed Company

ROGCIK 0000084748NYSELarge AcceleratedPlastic Materials, Synth Resins & Nonvulcan ElastomersMassachusettsCHFY ends Dec 31

Period

FY 2025

Revenue

$810.80M

Net Income

$-61.80M

Total Assets

$1.43B

Equity

$1.20B

Shares Out

17.85M

Op. Cash Flow

$101.20M

ROG$132.14+98.98% · past yearDBEQ Basic

Daily closing prices

Business

Rogers Corporation designs, develops, manufactures and sells high-performance engineered materials and components for demanding applications. Core offerings include circuit materials, ceramic substrates, busbars and cooling solutions (AES segment) and polyurethane, silicone, and fluoropolymer materials for cushioning, gasketing, sealing and thermal applications (EMS segment). The company serves EV/HEV, automotive, aerospace & defense, renewable energy, wireless infrastructure and industrial markets through direct sales to OEMs, component suppliers and distributors globally.

Summary from 10-K filed 2026-02-19

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	811	830	908	971	933
Cost of sales	554	553	601	650	584
Gross margin	257	277	307	321	349
Selling, general and administrative expenses	177	193	202	219	193
Research and development expenses	28	35	36	35	30
Restructuring and impairment charges	97	24	17	67	4
Other operating (income) expense, net	0	100,000	−33	−144	5
Operating income (loss)	−45	25	85	144	117
Equity income in unconsolidated joint ventures	0	1	2	4	7
Other income (expense), net	−900,000	9	−700,000	1	5
Interest income (expense), net	800,000	−800,000	−10	−10	−3
Income (loss) before income taxes	−45	34	76	140	126
Income tax expense	17	8	20	24	18
Net income (loss)	−62	26	57	117	108
Basic earnings (loss) per share (in dollars per share)	−3.4	1.4	3.04	6.21	5.77
Diluted earnings (loss) per share (in dollars per share)	−3.4	1.4	3.03	6.15	5.73
Basic earnings (loss) per share (in shares)	18	19	19	19	19
Diluted earnings (loss) per share (in shares)	18	19	19	19	19

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	197	160	132	236	232
Accounts receivable, net	131	135	162	177	163
Contract assets	28	24	45	39	37
Inventories, net	125	142	154	182	133
Asbestos-related insurance recoverables, current portion	5	4	4	4	3
Other current assets	15	29	30	21	14
Total current assets	500	494	527	660	584
Property, plant and equipment, net of accumulated depreciation	372	365	366	358	327
Operating lease right-of-use assets	19	24	19	13	—
Goodwill	303	358	360	352	370
Intangible assets, net of accumulated amortization	99	110	124	134	176
Asbestos-related insurance recoverables, non-current portion	48	48	52	56	59
Deferred income taxes	67	62	50	51	33
Other long-term assets	21	21	8	8	27
Total assets	1,430	1,481	1,517	1,646	1,599
Accounts payable	43	48	50	57	65
Accrued employee benefits and compensation	43	42	31	34	48
Accrued income taxes payable	10	8	2	6	10
Operating lease obligations, current portion	4	4	4	3	—
Asbestos-related liabilities, current portion	6	5	6	5	4
Other accrued liabilities	20	17	24	38	37
Total current liabilities	126	124	116	143	164
Operating lease obligations, non-current portion	18	21	15	11	—
Asbestos-related liabilities, non-current portion	52	52	56	60	64
Non-current income tax	5	6	7	10	7
Deferred income taxes	18	18	23	24	29
Other long-term liabilities	16	10	10	12	23
Commitments and contingencies (Note 6 and Note 10)	—	—	—	—	—
Capital stock - $1 par value; 50.0 authorized shares; 17.8 and 18.5 shares issued and outstanding, respectively	18	19	19	19	19
Additional paid-in capital	106	147	152	141	164
Retained earnings	1,119	1,181	1,155	1,098	982
Accumulated other comprehensive loss	−47	−95	−66	−85	−45
Total shareholders' equity	1,196	1,252	1,259	1,173	1,119
Total liabilities and shareholders' equity	1,430	1,481	1,517	1,646	1,599

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	54	49	51	46	43
Equity compensation expense	11	15	14	12	17
Deferred income taxes	−7	−17	−4	−21	−3
Dividends received from unconsolidated joint ventures	0	3	4	5	5
Gain on JV Separation Agreement transactions	0	−8	0	0	—
Gain on sale of business	0	0	−700,000	0	0
(Gain) loss on sale or disposal of property, plant and equipment	0	100,000	−3	500,000	−900,000
Impairment charges	74	8	0	65	500,000
Other non-cash charges, net	−200,000	3	600,000	400,000	—
Accounts receivable	11	19	−11	−32	−26
Proceeds from insurance related to operations	0	4	26	1	400,000
Contract assets	−2	20	−6	−4	—
Inventories, net	23	8	28	−52	−34
Other current assets	1	3	4	−6	2
Accounts payable and other accrued expenses	800,000	4	−27	−9	37
Other, net	−3	−8	−2	11	−8
Net cash provided by operating activities	101	127	131	130	124
Capital expenditures	−30	−56	−57	−117	−71
Disposition of business	0	0	2	0	0
Net cash from JV Separation Agreement transactions	0	8	0	0	—
Proceeds from the sale of marketable equity securities	1	2	0	0	—
Purchases of marketable equity securities	−200,000	−500,000	0	0	—
Proceeds from the sale of property, plant and equipment, net	14	1	6	0	700,000
Proceeds from insurance claims	0	0	2	7	0
Net cash used in investing activities	−15	−46	−48	−113	−239
Repayment of debt principal and finance lease obligations	−1	−30	−185	−75	−30
Line of credit issuance costs	0	0	−2	0	0
Payments of taxes related to net share settlement of equity awards	−1	−1	−3	−11	−3
Proceeds from issuance of shares to employee stock purchase plan	1	2	0	1	2
Share repurchases	−52	−20	0	−25	0
Net cash used in financing activities	−54	−50	−190	−10	159
Effect of exchange rate fluctuations on cash	5	−3	3	−3	−4
Net increase (decrease) in cash and cash equivalents	37	28	−104	4	41
Accrued capital additions	4	8	6	7	11
Interest, net of amounts capitalized	1	2	10	10	2
Income taxes, net of refunds	21	20	7	61	34

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is ROGERS CORP's CIK number?

ROGERS CORP's SEC CIK number is 0000084748 (84748). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find ROGERS CORP's SEC filings?

All of ROGERS CORP's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did ROGERS CORP last report earnings?

ROGERS CORP (ROG) most recently filed an earnings 8-K with the SEC on Apr 28, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000084748-26-000022). This is ROGERS CORP's most recent earnings filing of record — not a forecast of its next earnings date.

What is ROGERS CORP's most recent earnings 8-K?

ROGERS CORP's latest earnings 8-K (Item 2.02) was filed Apr 28, 2026 under accession 0000084748-26-000022. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View ROGERS CORP's latest earnings 8-K →
Look up any company's CIK number →